Free Trial

Mn Services Vermogensbeheer B.V. Sells 9,200 Shares of CME Group Inc. (NASDAQ:CME)

CME Group logo with Finance background

Mn Services Vermogensbeheer B.V. lessened its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 6.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 133,679 shares of the financial services provider's stock after selling 9,200 shares during the period. Mn Services Vermogensbeheer B.V.'s holdings in CME Group were worth $35,464,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. New Age Alpha Advisors LLC grew its stake in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after buying an additional 43 shares in the last quarter. Knuff & Co LLC bought a new position in CME Group in the fourth quarter valued at approximately $33,000. Banque Transatlantique SA bought a new stake in CME Group during the fourth quarter worth $35,000. Whipplewood Advisors LLC acquired a new stake in shares of CME Group in the 4th quarter valued at $37,000. Finally, United Community Bank acquired a new position in shares of CME Group during the 4th quarter worth $37,000. Institutional investors and hedge funds own 87.75% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CME. JPMorgan Chase & Co. decreased their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research report on Thursday, April 24th. Royal Bank of Canada reissued a "sector perform" rating and issued a $269.00 price objective on shares of CME Group in a research note on Thursday, April 3rd. UBS Group upped their price target on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a report on Friday, April 25th. Piper Sandler raised their price objective on CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Finally, Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. According to MarketBeat, CME Group presently has an average rating of "Hold" and a consensus price target of $258.20.

Get Our Latest Report on CME

CME Group Stock Performance

Shares of CME Group stock traded down $0.21 on Monday, reaching $269.29. 777,618 shares of the company traded hands, compared to its average volume of 2,332,366. The company has a 50 day moving average of $272.73 and a 200 day moving average of $254.51. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $290.79. The firm has a market capitalization of $97.04 billion, a PE ratio of 27.85, a PEG ratio of 6.76 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The business's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the business posted $2.50 earnings per share. Equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.86%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's dividend payout ratio (DPR) is presently 50.30%.

Insiders Place Their Bets

In other CME Group news, insider Derek Sammann sold 4,650 shares of the stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $280.61, for a total value of $1,304,836.50. Following the sale, the insider now directly owns 8,336 shares in the company, valued at $2,339,164.96. This represents a 35.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Larry G. Gerdes sold 2,000 shares of the company's stock in a transaction on Thursday, April 24th. The stock was sold at an average price of $264.10, for a total transaction of $528,200.00. Following the completion of the transaction, the director now directly owns 38,651 shares in the company, valued at approximately $10,207,729.10. The trade was a 4.92% decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,400 shares of company stock worth $3,680,610 over the last quarter. 0.30% of the stock is currently owned by company insiders.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines